Evidence map›Paper›PMID 33396896›Full record

ArticleCells2020

Human Adipose-Derived Stem Cells in Madelung's Disease: Morphological and Functional Characterization.

Federica Caponnetto, Ivana Manini, Michela Bulfoni, Nicola Zingaretti, Giovanni Miotti, Carla Di Loreto, Daniela Cesselli, Laura Mariuzzi, Pier Camillo Parodi

Abstract read
In one paragraph

Article in Cells, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. A Case Report of Madelung's Disease in Romania.Diagnostics (Basel, Switzerland) · 2025
    Article
  4. Article
  5. Article
  6. Review
  7. Study of a Subcutaneous Lesion of the Shoulder: The Saint Paolino Tumor.Plastic and reconstructive surgery. Global open · 2024
    Article
  8. Article
  9. Article
  10. A case report of Madelung's disease in China.Radiology case reports · 2022
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Federica CaponnettoDepartment of Medicine, University of Udine, 33100 Udine, Italy.
Ivana ManiniInstitute of Pathology, University Hospital of Udine, 33100 Udine, Italy.
Michela BulfoniDepartment of Medicine, University of Udine, 33100 Udine, Italy.ORCID 0000-0003-2646-4228
Nicola ZingarettiDepartment of Medical Area (DAME), Clinic of Plastic and Reconstructive Surgery, Academic Hospital of Udine, University of Udine, 33100 Udine, Italy.ORCID 0000-0002-1575-0029
Giovanni MiottiDepartment of Medical Area (DAME), Clinic of Plastic and Reconstructive Surgery, Academic Hospital of Udine, University of Udine, 33100 Udine, Italy.
Carla Di LoretoDepartment of Medicine, University of Udine, 33100 Udine, Italy.
Daniela CesselliDepartment of Medicine, University of Udine, 33100 Udine, Italy.ORCID 0000-0002-0562-7852
Laura MariuzziDepartment of Medicine, University of Udine, 33100 Udine, Italy.
Pier Camillo ParodiDepartment of Medicine, University of Udine, 33100 Udine, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Madelung Disease (MD) is a syndrome characterized by the accumulation of aberrant symmetric adipose tissue deposits. The etiology of this disease is yet to be elucidated, even though the presence of comorbidities, either genetic or environmental, has been reported. For this reason, establishing an in vitro model for MD is considered crucial to get insights into its physiopathology. We previously established a protocol for isolation and culture of stem cells from diseased tissues. Therefore, we isolated human adipose-derived stem cells (ASC) from MD patients and compared these cells with those isolated from healthy subjects in terms of surface phenotype, growth kinetic, adipogenic differentiation potential, and molecular alterations. Moreover, we evaluated the ability of the MD-ASC secretome to affect healthy ASC. The results reported a difference in the growth kinetic and surface markers of MD-ASC compared to healthy ASC but not in adipogenic differentiation. The most commonly described mitochondrial mutations were not observed. Still, MD-ASC secretome was able to shift the healthy ASC phenotype to an MD phenotype. This work provides evidence of the possibility of exploiting a patient-based in vitro model for better understanding MD pathophysiology, possibly favoring the development of novel target therapies.

Indexed as

Mesenchymal Stem CellsAdipose TissueCase-Control StudiesCell DifferentiationCell ProliferationHumansLipomatosis, Multiple SymmetricalMitochondriaPrimary Cell Culturehuman adipose-derived stem cellsLaunois–Bensaude syndromelipomatosisMadelung’s diseasemitochondrial mutations

Identifiers

PMID33396896
PMCPMC7824042

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.